Continuing research and development activities
First written in FY2017-Q1. 22 of 33 entries say "Restated". Latest entry: FY2027-H1.
90 other companies' latest entry also says "Other".
- FY2027-H1Increase in R&D Expenses for the Interim PeriodAnnual report
「Total R&D expense for the current interim consolidated accounting period was ¥40.202 million.」
R&D activities continued, with ¥40.202 million in R&D expense recorded for the interim cumulative period. This increased from ¥29.812 million in the previous interim consolidated accounting period. - FY2026Lower full-year R&D expensesAnnual report
「Total R&D expense for the consolidated fiscal year was ¥60.374 million.」
Research into new technologies and other areas continued to expand the functionality of the ASP business, but R&D expense decreased from ¥66.075 million in the previous fiscal year to ¥60.374 million. - FY2026-H1Decrease in interim R&D expenseAnnual report
「Total R&D expense for the current interim consolidated accounting period was ¥29.812 million.」
R&D activities continued, with ¥29.812 million in R&D expense recorded for the interim cumulative period. This was down from ¥35.877 million in the previous interim consolidated accounting period. - FY2025Increase in full-year R&D expensesAnnual report
「Total R&D expense for the consolidated fiscal year was ¥66.075 million.」
Research into new technologies and other areas continued with the aim of expanding ASP functionality, and R&D expense increased from ¥61.613 million in the previous fiscal year to ¥66.075 million. - FY2025-H1Increase in R&D Expenses for the Interim PeriodAnnual report
「Total R&D expense for the current interim consolidated accounting period was ¥35.877 million.」
R&D activities continued, with ¥35.877 million in R&D expense recorded for the interim cumulative period. - FY2025-Q1Increase in quarterly R&D expenseAnnual report
「Total R&D expense for the current first-quarter consolidated cumulative period was ¥18.628 million.」
R&D activities continued, with ¥18.628 million recorded as R&D expense. This increased from ¥12.602 million in the same period of the previous year. - FY2024-Q3Increase in R&D expensesAnnual report
「Total R&D expense for the current third-quarter consolidated cumulative period was ¥45.678 million. There were no significant changes in the status of the Group's R&D activities during the current third-quarter consolidated cumulative period.」
While stating that there were no significant changes in the status of R&D activities, the Company recorded ¥45.678 million in R&D expense. - FY2024-Q2Increase in R&D expensesAnnual report
「Total R&D expense for the current second-quarter consolidated cumulative period was ¥25.815 million. There were no significant changes in the status of the Group's R&D activities during the current second-quarter consolidated cumulative period.」
While stating that there were no significant changes in the status of R&D activities, the Company recorded ¥25.815 million in R&D expense. - FY2024-Q1RestatedAnnual report
「Total R&D expense for the current first-quarter consolidated cumulative period was ¥12.602 million.」
R&D activities continued, with ¥12.602 million in R&D expense recorded for the current quarter cumulative period. - FY2023-Q3RestatedAnnual report
「Total R&D expense for the current third-quarter consolidated cumulative period was ¥31.819 million. There were no significant changes in the status of the Group's R&D activities during the current third-quarter consolidated cumulative period.」
R&D activities continued, with ¥31.819 million in R&D expense recorded for the current third-quarter cumulative period. It is stated that there were no significant changes in the status of these activities. - FY2023-Q2RestatedAnnual report
「Total R&D expense for the current second-quarter consolidated cumulative period was ¥17.514 million. There were no significant changes in the status of the Group's R&D activities during the current second-quarter consolidated cumulative period.」
R&D activities continued, with ¥17.514 million recorded as R&D expense. It is stated that there were no significant changes in the status of these activities. - FY2023-Q1Quarterly R&D expenses declineAnnual report
「Total R&D expense for the current first-quarter consolidated cumulative period was ¥9.109 million.」
R&D activities continued, with ¥9.109 million recorded as R&D expense. This was down from ¥9.722 million in the same period of the previous year. - FY2022Increase in R&D expensesAnnual report
「The Company conducts research into these and other new technologies to expand the functionality of its ASP business (Makaseてネット) in response to technological innovation in internet-related technologies, next-generation mobile device technologies and security. Total R&D expense for the consolidated fiscal year was ¥34.700 million.」
Research into new technologies and other areas continued with the aim of expanding ASP functionality, and R&D expense increased from ¥32.644 million in the previous fiscal year to ¥34.700 million. - FY2022-Q2RestatedAnnual report
「Total R&D expense for the current second-quarter consolidated cumulative period was ¥17.514 million. There were no significant changes in the status of the Group's R&D activities during the current second-quarter consolidated cumulative period.」
R&D activities continued, with ¥17.514 million recorded as R&D expense. It is stated that there were no significant changes in the status of these activities. - FY2022-Q1RestatedAnnual report
「Total R&D expense for the current first-quarter consolidated cumulative period was ¥9.722 million.」
R&D activities continued, with ¥9.722 million in R&D expense recorded for the current quarter cumulative period. - FY2021-Q3RestatedAnnual report
「Total R&D expense for the current third-quarter consolidated cumulative period was ¥22.347 million. There were no significant changes in the status of the Group's R&D activities during the current third-quarter consolidated cumulative period.」
R&D activities continued, with ¥22.347 million recorded as R&D expense. It is stated that there were no significant changes in the status of these activities. - FY2021-Q2RestatedAnnual report
「Total R&D expense for the current second-quarter consolidated cumulative period was ¥13.363 million. There were no significant changes in the status of the Group's R&D activities during the current second-quarter consolidated cumulative period.」
R&D activities continued, with ¥13.363 million in R&D expense recorded for the current quarter cumulative period. It is stated that there were no significant changes in the status of R&D activities. - FY2021-Q1RestatedAnnual report
「Total R&D expense for the current first-quarter consolidated cumulative period was ¥6.904 million.」
R&D activities continued, with ¥6.904 million in R&D expense recorded for the current quarter cumulative period. - FY2020RestatedAnnual report
「The Company conducts research into these and other new technologies to expand the functionality of its ASP business (Makaseてネット) in response to technological innovation in internet-related technologies, next-generation mobile device technologies and security. Total R&D expense for the consolidated fiscal year was ¥32.644 million.」
Research into new technologies and other areas continued with the aim of expanding ASP functionality, and ¥32.644 million was recorded as R&D expense. - FY2020-Q3RestatedAnnual report
「Total R&D expense for the current third-quarter consolidated cumulative period was ¥25.605 million. There were no significant changes in the status of the Group's R&D activities during the current third-quarter consolidated cumulative period.」
R&D activities continued, with ¥25.605 million recorded as R&D expense. It is stated that there were no significant changes in the status of these activities. - FY2020-Q2RestatedAnnual report
「Total R&D expense for the current second-quarter consolidated cumulative period was ¥18.400 million. There were no significant changes in the status of the Group's R&D activities during the current second-quarter consolidated cumulative period.」
R&D activities continued, with ¥18.400 million recorded as R&D expense. It is stated that there were no significant changes in the status of these activities. - FY2020-Q1RestatedAnnual report
「Total R&D expense for the current first-quarter consolidated cumulative period was ¥11.217 million.」
R&D activities continued, with ¥11.217 million in R&D expense recorded for the current quarter cumulative period. - FY2019-Q3RestatedAnnual report
「R&D expenses for the first three quarters of the current consolidated fiscal year totaled ¥24.054 million. There were no material changes in the status of the Group's R&D activities during the first three quarters of the current consolidated fiscal year.」
R&D activities continued, with ¥24.054 million recorded as R&D expense. It is stated that there were no significant changes in the status of these activities. - FY2019-Q2RestatedAnnual report
「R&D expenses for the first two quarters of the current consolidated fiscal year totaled ¥16.630 million. There were no material changes in the status of the Group's R&D activities during the first two quarters of the current consolidated fiscal year.」
R&D activities continued, with ¥16.630 million in R&D expenses recorded. The company stated that there were no material changes in the status of these activities. - FY2019-Q1RestatedAnnual report
「R&D expenses for the first quarter of the current consolidated fiscal year totaled ¥9.183 million.」
R&D activities continued, with ¥9.183 million in R&D expenses recorded for the cumulative quarter-to-date period. - FY2018RestatedAnnual report
「The company is conducting research into these and other new technologies to expand the functionality of its ASP business, Makasete Net, in response to technological advances in internet-related technologies, next-generation mobile device technologies and security. R&D expenses for the current consolidated fiscal year totaled ¥30.021 million.」
Research into the internet, next-generation mobile devices and security continued with the aim of expanding ASP functionality. R&D expenses totaled ¥30.021 million. - FY2018-Q3RestatedAnnual report
「R&D expenses for the first three quarters of the current consolidated fiscal year totaled ¥21.655 million. There were no material changes in the status of the Group's R&D activities during the first three quarters of the current consolidated fiscal year.」
R&D activities continued, with ¥21.655 million in R&D expenses recorded for the cumulative quarter-to-date period. The company stated that there were no material changes in the status of these activities. - FY2018-Q2RestatedAnnual report
「R&D expenses for the first two quarters of the current consolidated fiscal year totaled ¥13.196 million.」
R&D activities continued, with ¥13.196 million in R&D expenses recorded for the cumulative quarter-to-date period. - FY2018-Q1RestatedAnnual report
「R&D expenses for the first quarter of the current consolidated fiscal year totaled ¥6.966 million.」
R&D activities continued, with ¥6.966 million in R&D expenses recorded for the cumulative quarter-to-date period. - FY2017RestatedAnnual report
「The company is conducting research into these and other new technologies to expand the functionality of its ASP business, Makasete Net, in response to technological advances in internet-related technologies, next-generation mobile device technologies and security. R&D expenses for the current consolidated fiscal year totaled ¥29.463 million.」
Research into the internet, next-generation mobile devices and security continued with the aim of expanding ASP functionality. - FY2017-Q3RestatedAnnual report
「R&D expenses for the first three quarters of the current consolidated fiscal year totaled ¥22.540 million.」
R&D activities continued, with ¥22.540 million in R&D expenses recorded for the cumulative quarter-to-date period. - FY2017-Q2RestatedAnnual report
「R&D expenses for the first two quarters of the current consolidated fiscal year totaled ¥14.854 million.」
R&D activities continued, with ¥14.854 million in R&D expenses recorded for the cumulative quarter-to-date period. - FY2017-Q1First statedAnnual report
「R&D expenses for the first quarter of the current consolidated fiscal year totaled ¥7.282 million.」
R&D expenses were recorded during the quarter, but no specific R&D themes or targets were disclosed.